Consistent with these data, as an example, heterozygous loss of ATG5 enhances disease progression and aggressiveness of an MLL-ENL (mixed lineage leukemia—eleven nineteen leukemia)-driven AML mouse model [22]. Here, ATG5 is linked to acute myeloid leukemia.